Advanced therapies, medicines bring new hope for pulmonary hypertension patients: Dr Manisha Mendiratta: Shardul Nautiyal, Mumbai Saturday, February 8, 2025, 08:00 Hrs [IST] Dr Ma ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

This increased pulmonary pressure gradually causes worsening exercise capacity ... Although several Group 1 PH (Pulmonary Arterial Hypertension, “PAH”) medications have been explored in Group 2 PH, to ...

This increased pulmonary pressure gradually causes worsening exercise capacity ... Although several Group 1 PH (Pulmonary Arterial Hypertension, "PAH") medications have been explored in Group ...

Exercise intolerance is one of the primary symptons of pulmonary arterial hypertension, significantly impacting the quality of life. The pathophysiology of exercise intolerance in pulmonary arterial ...

According to the NHS, atherosclerosis occurs when arteries become narrowed, making it difficult for blood to flow through ...

Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 millionReceived CE Mark for LungFit PH® in ...

The numbers represent Negros Occidental families struggling with the rising costs of health care, households blindsided by a sudden stroke, and lives upended by an avoidable crisis ...

A 41-year-old man was evaluated for swelling in the ankles and syncope. CT of the chest showed bilateral mediastinal and ...

ABSTRACT: This study examines hemodynamic behavior in particular cases of pulmonary hypertension without treatment. Pulmonary hypertension represents an anomalous hemodynamic state and is ...